Cited by 4,917Antifungal resistance and susceptibilityFungal Infections and StudiesNeutropenia and Cancer Infections

The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.

Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group

Open access

De Pauw, Ben, Walsh, Thomas J., Donnelly, J. Peter, Stevens, David A., Edwards, John E., Calandra, Thierry, Pappas, Peter G., Maertens, Johan, Lortholary, Olivier, Kauffman, Carol A., Denning, David W., Patterson, Thomas F., Maschmeyer, Georg, Bille, Jacques, Dismukes, William E., Herbrecht, Raoul, Hope, William W., Kibbler, Christopher C., Kullberg, Bart Jan, Marr, Kieren A., Muñoz, Patricia, Odds, Frank C., Perfect, John R., Restrepo, Angela, Ruhnke, Markus, Segal, Brahm H., Sobel, Jack D., Sorrell, Tania C., Viscoli, Claudio, Wingard, John R., Zaoutis, Theoklis, Bennett, John E.·2008·Clinical Infectious Diseases

DOI 10.1086/588660PMC PMC2671227

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND: Invasive fungal diseases are important causes of morbidity and mortality. Clarity and uniformity in defining these infections are important factors in improving the quality of clinical studies. A standard set of definitions strengthens the consistency and reproducibility of such studies. METHODS: After the introduction of the original European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group definitions, advances in diagnostic technology and the recognition of areas in need of improvement led to a revision of this document. The revision process started with a meeting of participants in 2003, to decide on the process and to draft the proposal. This was followed by several rounds of consultation until a final draft was approved in 2005. This was made available for 6 months to allow public comment, and then the manuscript was prepared and approved. RESULTS: The revised definitions retain the original classifications of "proven," "probable," and "possible" invasive fungal disease, but the definition of "probable" has been expanded, whereas the scope of the category "possible" has been diminished. The category of proven invasive fungal disease can apply to any patient, regardless of whether the patient is immunocompromised, whereas the probable and possible categories are proposed for immunocompromised patients only. CONCLUSIONS: These revised definitions of invasive fungal disease are intended to advance clinical and epidemiological research and may serve as a useful model for defining other infections in high-risk patients.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1086/588660

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis
Herbrecht, R., Denning, D. W., Patterson, T. F., Bennett, J. E., Greene, R. E., Oestmann, J.-W., Kern, W. V., Marr, K. A., Ribaud, P., Lortholary, O., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020191 · Cited by 3,304
Self-citation
Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America
Walsh, T. J., Anaissie, E. J., Denning, D. W., Herbrecht, R., Kontoyiannis, D. P., Marr, K. A., Morrison, V. A., Segal, B. H., Steinbach, W. J., Stevens, D. A., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/525258 · Cited by 2,705
Self-citation
Defining Opportunistic Invasive Fungal Infections in Immunocompromised Patients with Cancer and Hematopoietic Stem Cell Transplants: An International Consensus
Aşçıoğlu, S., Rex, J. H., de Pauw, B., Bennett, J. E., Billé, J., Crokaert, F., Denning, D. W., Donnelly, J. P., Edwards, J. E., Erjavec, Z., et al. (2002) · Clinical Infectious Diseases · doi:10.1086/323335 · Cited by 2,315
Self-citation
Posaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia
Cornely, O. A., Maertens, J. A., Winston, D. J., Perfect, J. R., Ullmann, A. J., Walsh, T. J., HELFGOTT, D. C., Hołowiecki, J., Stockelberg, D., Goh, Y. T., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa061094 · Cited by 1,802
Self-citation
Posaconazole or Fluconazole for Prophylaxis in Severe Graft-versus-Host Disease
Ullmann, A. J., Lipton, J. H., Vesole, D. H., Chandrasekar, P. H., Langston, A. A., Tarantolo, S., Greinix, H., de Azevedo, W. M., Reddy, V. S., Boparai, N., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa061098 · Cited by 1,339
Voriconazole Compared with Liposomal Amphotericin B for Empirical Antifungal Therapy in Patients with Neutropenia and Persistent Fever
Walsh, T. J., Pappas, P., Winston, D. J., Lazarus, H. M., Petersen, F., Raffalli, J., Yanovich, S., Stiff, P., Greenberg, R., Donowitz, G., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejm200201243460403 · Cited by 979
Self-citation
Caspofungin versus Liposomal Amphotericin B for Empirical Antifungal Therapy in Patients with Persistent Fever and Neutropenia
Walsh, T. J., Teppler, H., Donowitz, G. R., Maertens, J. A., Baden, L. R., Dmoszyńska, A., Cornely, O. A., Bourque, M. R., Lupinacci, R. J., Sable, C. A., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040446 · Cited by 907
Self-citation
Glossary of terms for CT of the lungs: recommendations of the Nomenclature Committee of the Fleischner Society.
Austin, J. H. M., Müller, N. L., Friedman, P. J., Hansell, D. M., Naidich, D. P., Rémy-Jardin, M., Webb, W. R., & Zerhouni, E. A. (1996) · Radiology · doi:10.1148/radiology.200.2.8685321 · Cited by 836
Invasive Aspergillosis Disease Spectrum, Treatment Practices, and Outcomes
Patterson, T. F., Kirkpatrick, W. R., White, M., Hiemenz, J. W., WINGARD, J. R., DUPONT, B., RINALDI, M. G., STEVENS, D. A., & Graybill, J. R. (2000) · Medicine · doi:10.1097/00005792-200007000-00006 · Cited by 791
Self-citation
Liposomal Amphotericin B as Initial Therapy for Invasive Mold Infection: A Randomized Trial Comparing a High-Loading Dose Regimen with Standard Dosing (AmBiLoad Trial)
Cornely, O. A., Maertens, J. A., Bresnik, M., Ebrahimi, R., Ullmann, A. J., Bouza, E., Heußel, C. P., Lortholary, O., Rieger, C. T., Boehme, A., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/514341 · Cited by 744
Self-citation

Flagged first, then by citations

Show all 28 references

Sorted by citations

Items 201–300 of 1,024

Invasive fungal breakthrough infections, fungal colonization and emergence of resistant strains in high-risk patients receiving antifungal prophylaxis with posaconazole: real-life data from a single-centre institutional retrospective observational study
Auberger, J., Lass‐Flörl, C., Aigner, M., Clausen, J., Gastl, G. A., & Nachbaur, D. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks189 · Cited by 156
Evaluation of Real-Time PCR, Galactomannan Enzyme-Linked Immunosorbent Assay (ELISA), and a Novel Lateral-Flow Device for Diagnosis of Invasive Aspergillosis
White, P. L., Parr, C., Thornton, C. R., & Barnes, R. A. (2013) · Journal of Clinical Microbiology · doi:10.1128/jcm.03189-12 · Cited by 155
An EORTC Phase II study of caspofungin as first-line therapy of invasive aspergillosis in haematological patients
Viscoli, C., Herbrecht, R., Akan, H., Baila, L., Sonet, A., Gallamini, A., Giagounidis, A., Marchetti, O., Martino, R., Meert, L., et al. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp355 · Cited by 154
Self-citation
Pneumocystis jiroveciiDisease: Basis for the Revised EORTC/MSGERC Invasive Fungal Disease Definitions in Individuals Without Human Immunodeficiency Virus
Lagrou, K., Chen, W., Masur, H., Viscoli, C., Decker, C. F., Pagano, L., & Groll, A. H. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1805 · Cited by 154
Self-citation
Pathogenesis of Respiratory Viral and Fungal Coinfections
Salazar, F., Bignell, E., Brown, G. D., Cook, P. C., & Warris, A. (2021) · Clinical Microbiology Reviews · doi:10.1128/cmr.00094-21 · Cited by 164
A Breath Fungal Secondary Metabolite Signature to Diagnose Invasive Aspergillosis
Koo, S., Thomas, H. R., Daniels, S. D., Lynch, R. C., Fortier, S. M., Shea, M. M., Rearden, P., Comolli, J. C., Baden, L. R., & Marty, F. M. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu725 · Cited by 153
Risk Factors for Invasive Fungal Disease in Pediatric Cancer and Hematopoietic Stem Cell Transplantation: A Systematic Review
Fisher, B. T., Robinson, P. D., Lehrnbecher, T., Steinbach, W. J., Zaoutis, T. E., Phillips, B., & Sung, L. (2017) · Journal of the Pediatric Infectious Diseases Society · doi:10.1093/jpids/pix030 · Cited by 153
Self-citation
Clinical Practice Guideline for Systemic Antifungal Prophylaxis in Pediatric Patients With Cancer and Hematopoietic Stem-Cell Transplantation Recipients
Lehrnbecher, T., Fisher, B. T., Phillips, B., Beauchemin, M., Carlesse, F. A. D. M. C., Castagnola, E., Duong, N., Dupuis, L. L., Fioravantti, V., Groll, A. H., et al. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.20.00158 · Cited by 153
Rare opportunistic (non-Candida, non-Cryptococcus) yeast bloodstream infections in patients with cancer
Chitasombat, M. N., Kofteridis, D. P., Jiang, Y., Tarrand, J., Lewis, R. E., & Kontoyiannis, D. P. (2012) · Journal of Infection · doi:10.1016/j.jinf.2011.11.002 · Cited by 152
Pulmonary fungal infections
Smith, J. A., & Kauffman, C. A. (2012) · Respirology · doi:10.1111/j.1440-1843.2012.02150.x · Cited by 151
Self-citation
Pulmonary Involvement in Patients With Hemophagocytic Lymphohistiocytosis
Seguin, A., Galicier, L., Boutboul, D., Lemiale, V., & Azoulay, É. (2016) · CHEST Journal · doi:10.1016/j.chest.2015.11.004 · Cited by 151
Diagnostic Accuracy of PCR Alone Compared to Galactomannan in Bronchoalveolar Lavage Fluid for Diagnosis of Invasive Pulmonary Aspergillosis: a Systematic Review
Avni, T., Levy, I., Sprecher, H., Yahav, D., Leibovici, L., & Paul, M. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.00942-12 · Cited by 151
Diagnostic accuracy of serum (1-3)-β-D-glucan for Pneumocystis jirovecii pneumonia: a systematic review and meta-analysis
Corpo, O. D., Butler‐Laporte, G., Sheppard, D. C., Cheng, M. P., McDonald, E. G., & Lee, T. C. (2020) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2020.05.024 · Cited by 152
Risk stratification for invasive aspergillosis in immunocompromised patients
Herbrecht, R., Bories, P., Moulin, J., Ledoux, M., & Letscher‐Bru, V. (2012) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2012.06829.x · Cited by 148
Self-citation
PCR in Diagnosis of Invasive Aspergillosis: a Meta-Analysis of Diagnostic Performance
Arvanitis, M., Ziakas, P. D., Zacharioudakis, I. M., Zervou, F. N., Caliendo, A. M., & Mylonakis, E. E. (2014) · Journal of Clinical Microbiology · doi:10.1128/jcm.01365-14 · Cited by 150
Posaconazole Exposure-Response Relationship: Evaluating the Utility of Therapeutic Drug Monitoring
Dolton, M. J., Ray, J. E., Marriott, D. J. E., & McLachlan, A. J. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05900-11 · Cited by 148
Comparison of computed tomographic findings in pulmonary mucormycosis and invasive pulmonary aspergillosis
Jung, J., Kim, M. Y., Lee, H. J., Park, Y. S., Lee, S.-O., Choi, S., Kim, Y. S., Woo, J. H., & Kim, S. (2015) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2015.03.019 · Cited by 147
Invasive aspergillosis in patients with severe alcoholic hepatitis
Gustot, T., Maillart, E., Bocci, M., Surin, R., Trépo, E., Degré, D., Lucidi, V., Taccone, F. S., Delforge, M., Vincent, J., et al. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.09.011 · Cited by 146
Diagnosis and antimicrobial therapy of lung infiltrates in febrile neutropenic patients (allogeneic SCT excluded): updated guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO)
Maschmeyer, G., Carratalà, J., Buchheidt, D., Hamprecht, A. G., Heußel, C. P., Kahl, C., Lorenz, J., Neumann, S., Rieger, C. T., Ruhnke, M., et al. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu192 · Cited by 146
Self-citation
Endemic fungal infections in solid organ transplant recipients—Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice
Miller, R. A., Assi, M., & Practice, T. A. I. D. C. O. (2019) · Clinical Transplantation · doi:10.1111/ctr.13553 · Cited by 146
Comparison of an Aspergillus Real-time Polymerase Chain Reaction Assay With Galactomannan Testing of Bronchoalvelolar Lavage Fluid for the Diagnosis of Invasive Pulmonary Aspergillosis in Lung Transplant Recipients
Luong, M., Clancy, C. J., Vadnerkar, A., Kwak, E. J., Silveira, F. P., Wissel, M., Grantham, K. J., Shields, R. K., Crespo, M. M., Pilewski, J. M., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir185 · Cited by 144
Self-citation
Guidance on Imaging for Invasive Pulmonary Aspergillosis and Mucormycosis: From the Imaging Working Group for the Revision and Update of the Consensus Definitions of Fungal Disease from the EORTC/MSGERC
Alexander, B. D., Lamoth, F., Heußel, C. P., Schaefer‐Prokop, C. M., Desai, S. R., Morrissey, C. O., & Baddley, J. W. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1855 · Cited by 144
Advances in the diagnosis and treatment of fungal infections of the CNS
Schwartz, S., Kontoyiannis, D. P., Harrison, T. S., & Ruhnke, M. (2018) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30030-9 · Cited by 145
Self-citation
The strategy for the diagnosis of invasive pulmonary aspergillosis should depend on both the underlying condition and the leukocyte count of patients with hematologic malignancies
Bergeron, A., Porcher, R., Sulahian, A., de BAZELAIRE, C., Chagnon, K., Raffoux, E., Vekhoff, A., Cornet, M., Isnard, F., Brethon, B., et al. (2011) · Blood · doi:10.1182/blood-2011-04-351601 · Cited by 142
Epidemiology and Outcome of Fungemia in a Cancer Cohort of the Infectious Diseases Group (IDG) of the European Organization for Research and Treatment of Cancer (EORTC 65031)
Cornely, O. A., Gachot, B., Akan, H., Bassetti, M., Uzun, Ö., Kibbler, C. C., Marchetti, O., de Burghgraeve, P., Ramadan, S., Pylkkänen, L., et al. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ293 · Cited by 142
Self-citation
Bronchoalveolar Lavage and Lung Biopsy in Patients With Cancer and Hematopoietic Stem-Cell Transplantation Recipients: A Systematic Review and Meta-Analysis
Chellapandian, D., Lehrnbecher, T., Phillips, B., Fisher, B. T., Zaoutis, T. E., Steinbach, W. J., Beyene, J., & Sung, L. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.58.0480 · Cited by 144
Self-citation
Chinese guidelines for the diagnosis and treatment of hospital-acquired pneumonia and ventilator-associated pneumonia in adults (2018 Edition)
Shi, Y. P., Huang, Y. X., Zhang, T., Cao, B., Wang, H., Zhuo, C., Ye, F., Su, X., Fan, H. S., Xu, J., et al. (2019) · Journal of Thoracic Disease · doi:10.21037/jtd.2019.06.09 · Cited by 144
Invasive fungal sinusitis in patients with hematological malignancy: 15 years experience in a single university hospital in Taiwan
Chen, C., Sheng, W., Cheng, A., Chen, Y., Tsay, W., Tang, J., Huang, S., Chang, S., & Tien, H. (2011) · BMC Infectious Diseases · doi:10.1186/1471-2334-11-250 · Cited by 141
Acute Invasive Fungal Rhinosinusitis: A Comprehensive Update of CT Findings and Design of an Effective Diagnostic Imaging Model
Middlebrooks, E. H., Frost, C., Jesus, R. O. D., Massini, T. C., Schmalfuss, I. M., & Mancuso, A. (2015) · American Journal of Neuroradiology · doi:10.3174/ajnr.a4298 · Cited by 141
Diagnosis and Treatment of Pulmonary Aspergillosis Syndromes
Patterson, K. C., & Strek, M. E. (2014) · CHEST Journal · doi:10.1378/chest.14-0917 · Cited by 143
Clinical Performance of Aspergillus PCR for Testing Serum and Plasma: a Study by the European Aspergillus PCR Initiative
White, P. L., Barnes, R. A., Springer, J., Klingspor, L., Cuenca-Estrella, M., Morton, C. O., Lagrou, K., Bretagne, S., Melchers, W. J. G., Mengoli, C., et al. (2015) · Journal of Clinical Microbiology · doi:10.1128/jcm.00905-15 · Cited by 140
Self-citation
A systematic review and meta-analysis of diagnostic accuracy of serum 1,3-β-d-glucan for invasive fungal infection: Focus on cutoff levels
He, S., Hang, J.-P., Zhang, L., Wang, F., Zhang, D., & Gong, F.-H. (2014) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2014.06.009 · Cited by 140
Voriconazole Use for Endemic Fungal Infections
Freifeld, A. G., Proia, L. A., Andes, D. R., Baddour, L. M., Blair, J. E., Spellberg, B. J., Arnold, S. R., Lentnek, A. L., & Wheat, L. J. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01148-07 · Cited by 140
Valganciclovir for the Prevention of Complications of Late Cytomegalovirus Infection After Allogeneic Hematopoietic Cell Transplantation
Boeckh, M., Nichols, W. G., Chemaly, R. F., Papanicolaou, G. A., Wingard, J. R., Xie, H., Syrjala, K. L., Flowers, M. E. D., Stevens‐Ayers, T., Jerome, K. R., et al. (2015) · Annals of Internal Medicine · doi:10.7326/m13-2729 · Cited by 140
Self-citation
Dectin-1 and DC-SIGN Polymorphisms Associated with Invasive Pulmonary Aspergillosis Infection
Sáinz, J., Lupiañez, C. B., Segura-Catena, J., Vázquez, L., Ríos, R., Oyonarte, S., Hemminki, K., Försti, A., & Jurado, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032273 · Cited by 143
Influenza virus and factors that are associated with ICU admission, pulmonary co-infections and ICU mortality
Beumer, M. C., Koch, R. M., Beuningen, D. V., Oudelashof, A. M., van de Veerdonk, F. L., Kolwijck, E., van der Hoeven, J. G., Bergmans, D. C. J. J., & Hoedemaekers, C. (2018) · Journal of Critical Care · doi:10.1016/j.jcrc.2018.11.013 · Cited by 141
Invasive fungal infections in pediatric oncology
Mor, M., Gilad, G., Kornreich, L., Fisher, S., Yaniv, I., & Levy, I. (2011) · Pediatric Blood & Cancer · doi:10.1002/pbc.23005 · Cited by 138
Effect of low‐to‐moderate‐dose corticosteroids on mortality of hospitalized adolescents and adults with influenza A(H1N1)pdm09 viral pneumonia
Li, H., Yang, S., Gu, L., Zhang, Y., Yan, X., Liang, Z., Zhang, W., Jia, H., Chen, W., Liu, M., et al. (2017) · Influenza and Other Respiratory Viruses · doi:10.1111/irv.12456 · Cited by 138
Invasive Candida infections in surgical patients in intensive care units: a prospective, multicentre survey initiated by the European Confederation of Medical Mycology (ECMM) (2006–2008)
Klingspor, L., Tortorano, A. M., Peman, J., Willinger, B., Hamal, P., Sendid, B., Velegraki, A., Kibbler, C., Meis, J. F., Sabino, R., et al. (2015) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2014.08.011 · Cited by 137
Self-citation
Diagnosis and therapy of Candida infections: joint recommendations of the German Speaking Mycological Society and the Paul-Ehrlich-Society for Chemotherapy
Ruhnke, M., Rickerts, V., Cornely, O. A., Buchheidt, D., Glöckner, A., Heinz, W., Höhl, R., Horré, R., Karthaus, M., Kujath, P., et al. (2011) · Mycoses · doi:10.1111/j.1439-0507.2011.02040.x · Cited by 140
Self-citation
Procalcitonin (PCT) levels for ruling-out bacterial coinfection in ICU patients with influenza: A CHAID decision-tree analysis
Rodríguez, A. H., Avilés‐Jurado, F. X., Díaz, E., Schüetz, P., Trefler, S., Solé‐Violán, J., Cordero, L., Vidaur, L., Estella, Á., Pozo, J. C., et al. (2015) · Journal of Infection · doi:10.1016/j.jinf.2015.11.007 · Cited by 136
Timeline, Epidemiology, and Risk Factors for Bacterial, Fungal, and Viral Infections in Children and Adolescents after Allogeneic Hematopoietic Stem Cell Transplantation
Srinivasan, A., Wang, C., Srivastava, D. K., Burnette, K., Shenep, J. L., Leung, W. H., & Hayden, R. T. (2012) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2012.08.012 · Cited by 134
Epidemiology, outcomes, and mortality predictors of invasive mold infections among transplant recipients: a 10‐year, single‐center experience
Neofytos, D., Treadway, S., Ostrander, D. B., Alonso, C. D., Dierberg, K. L., Nussenblatt, V. R., Durand, C. M., Thompson, C. B., & Marr, K. A. (2013) · Transplant Infectious Disease · doi:10.1111/tid.12060 · Cited by 134
Self-citation
Invasive Aspergillosis Associated With Severe Influenza Infections
Crum‐Cianflone, N. F. (2016) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofw171 · Cited by 134
Utility of bronchoalveolar lavage fluid galactomannan alone or in combination with PCR for the diagnosis of invasive aspergillosis in adult hematology patients: A systematic review and meta-analysis
Heng, S. C., Morrissey, O., Chen, S. C.-A., Thursky, K., Manser, R. L., Nation, R. L., Kong, D. C.-M., & Slavin, M. (2015) · Critical Reviews in Microbiology · doi:10.3109/1040841x.2013.804033 · Cited by 133
Infections after T‐replete haploidentical transplantation and high‐dose cyclophosphamide as graft‐versus‐host disease prophylaxis
Crocchiolo, R., Bramanti, S., Vai, A., Sarina, B., Mineri, R., Casari, E., Tordato, F., Mauro, E. D., Timofeeva, I., Lugli, E., et al. (2015) · Transplant Infectious Disease · doi:10.1111/tid.12365 · Cited by 133
Acute myeloid leukaemia: challenges and real world data from India
Philip, C. C., George, B., Ganapule, A., Korula, A., Jain, P. L., Alex, A. A., Lakshmi, K. M., Sitaram, U., Abubacker, F. N., Abraham, A., et al. (2015) · British Journal of Haematology · doi:10.1111/bjh.13406 · Cited by 133
Diagnosis of Invasive Aspergillosis by a Commercial Real-Time PCR Assay for Aspergillus DNA in Bronchoalveolar Lavage Fluid Samples from High-Risk Patients Compared to a Galactomannan Enzyme Immunoassay
Torelli, R., Sanguinetti, M., Moody, A., Pagano, L., Caira, M., Carolis, E. D., Fuso, L., PASCALE, G. D., Bello, G., Antonelli, M. M., et al. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.05026-11 · Cited by 133
Fungal infections diagnosis – Past, present and future
Mendonça, A., Santos, H., Franco‐Duarte, R., & Sampaio, P. (2021) · Research in Microbiology · doi:10.1016/j.resmic.2021.103915 · Cited by 133
Invasive Mold Infections in Chronic Granulomatous Disease: A 25-Year Retrospective Survey
Blumental, S., Mouy, R., Mahlaoui, N., Bougnoux, M., Debré, M., Beauté, J., Lortholary, O., Blanche, S., & Fischer, A. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir731 · Cited by 134
Self-citation
(1,3)- -D-Glucan as a Prognostic Marker of Treatment Response in Invasive Candidiasis
Jaijakul, S., Vázquez, J. A., Swanson, R. N., & Ostrosky-Zeichner, L. L. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis456 · Cited by 137
PCR-based detection of Aspergillus fumigatus Cyp51A mutations on bronchoalveolar lavage: a multicentre validation of the AsperGenius assay ® in 201 patients with haematological disease suspected for invasive aspergillosis
Chong, G. M., van der Beek, M. T., Borne, P. A. V. D., Boelens, J., Steel, E., Kampinga, G. A., Span, L. F. R., Lagrou, K., Maertens, J. A., Dingemans, G., et al. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw323 · Cited by 132
Self-citation
Torque teno virus for risk stratification of graft rejection and infection in kidney transplant recipients—A prospective observational trial
Doberer, K., Schiemann, M., Straßl, R. P., Haupenthal, F., Dermuth, F., Görzer, I., Eskandary, F. A., Reindl‐Schwaighofer, R., Kikić, Ž., Puchhammer‐Stöckl, E., et al. (2020) · American Journal of Transplantation · doi:10.1111/ajt.15810 · Cited by 132
Antithymocyte Globulin for Matched Sibling Donor Transplantation in Patients With Hematologic Malignancies: A Multicenter, Open-Label, Randomized Controlled Study
Chang, Y., Wu, D., Lai, Y., Liu, Q., Sun, Y., Hu, J., Hu, Y., Zhou, J., Li, J., Wang, S., et al. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.20.00150 · Cited by 132
Phaeohyphomycosis in a Tertiary Care Cancer Center
Ben‐Ami, R., Lewis, R. E., RAAD, I. I., & Kontoyiannis, D. P. (2009) · Clinical Infectious Diseases · doi:10.1086/597400 · Cited by 131
Prospective, Observational Study of Voriconazole Therapeutic Drug Monitoring among Lung Transplant Recipients Receiving Prophylaxis: Factors Impacting Levels of and Associations between Serum Troughs, Efficacy, and Toxicity
Mitsani, D., Nguyen, M. H., Shields, R. K., Toyoda, Y., Kwak, E. J., Silveira, F. P., Pilewski, J. M., Crespo, M. M., Bermudez, C. A., Bhama, J. K., et al. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05219-11 · Cited by 130
Mucormycosis Outbreak Associated With Hospital Linens
Duffy, J., Harris, J., Gade, L., Sehulster, L. M., Newhouse, E., Moulton-Meissner, H. A., Noble‐Wang, J., Rao, C. Y., Balajee, S. A., & Chiller, T. M. (2014) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000000261 · Cited by 130
Plasma Microbial Cell-free DNA Next-generation Sequencing in the Diagnosis and Management of Febrile Neutropenia
Benamu, E., Gajurel, K., Anderson, J. N., Lieb, T., Gómez, C. A., Seng, H., Aquino, R., Hollemon, D., Hong, D. K., Blauwkamp, T. A., et al. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciab324 · Cited by 130
Detection of a Molecular Biomarker for Zygomycetes by Quantitative PCR Assays of Plasma, Bronchoalveolar Lavage, and Lung Tissue in a Rabbit Model of Experimental Pulmonary Zygomycosis
Kasai, M., Harrington, S. M., Francesconi, A., Petraitis, V., Petraitienė, R., Beveridge, M. G., Knudsen, T. A., Milanovich, J., Cotton, M. P., Hughes, J. E., et al. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.00917-08 · Cited by 130
Self-citation
Risks, severity and timing of infections in patients with multiple myeloma: a longitudinal cohort study in the era of immunomodulatory drug therapy
Teh, B. W., Harrison, S. J., Worth, L. J., Spelman, T. D., Thursky, K., & Slavin, M. A. (2015) · British Journal of Haematology · doi:10.1111/bjh.13532 · Cited by 129
Novel Tests for Diagnosis of Invasive Aspergillosis in Patients with Underlying Respiratory Diseases
Prattes, J., Flick, H., Prüller, F., Koidl, C., Raggam, R. B., Palfner, M., Eigl, S., Buzina, W., Zollner‐Schwetz, I., Thornton, C. R., et al. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201407-1275oc · Cited by 130
Monitoring trough concentration of voriconazole is important to ensure successful antifungal therapy and to avoid hepatic damage in patients with hematological disorders
Ueda, K., Nannya, Y., Kumano, K., Hangaishi, A., Takahashi, T., Imai, Y., & Kurokawa, M. (2009) · International Journal of Hematology · doi:10.1007/s12185-009-0296-3 · Cited by 129
Detection and investigation of invasive mould disease
Cuenca‐Estrella, M., Bassetti, M., Lass‐Flörl, C., Racil, Z., Richardson, M. D., & Rogers, T. R. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq438 · Cited by 129
Cerebro-rhino orbital mucormycosis: An update
Wali, U., Balkhair, A., & Al-Mujaini, A. S. (2012) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2012.01.003 · Cited by 128
Mucorales-specific T cells emerge in the course of invasive mucormycosis and may be used as a surrogate diagnostic marker in high-risk patients
Potenza, L., Vallerini, D., Barozzi, P., Riva, G., Forghieri, F., Zanetti, E., Quadrelli, C., Candoni, A., Maertens, J. A., Rossi, G., et al. (2011) · Blood · doi:10.1182/blood-2011-07-366526 · Cited by 128
Self-citation
Mucormycosis in Australia: contemporary epidemiology and outcomes
Kennedy, K., Daveson, K., Slavin, M. A., van Hal, S. J., Sorrell, T. C., Lee, A., Marriott, D. J. E., Chapman, B., Halliday, C. L., Hajkowicz, K. M., et al. (2016) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2016.01.005 · Cited by 128
Self-citation
Early diagnosis of invasive mould infections and disease
Lamoth, F., & Calandra, T. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx030 · Cited by 126
Self-citation
Epidemiology and treatment outcome of invasive fungal infections in patients with hematological malignancies
Kurosawa, M., Yonezumi, M., Hashino, S., Tanaka, J., Nishio, M., Kaneda, M., Ota, S., Koda, K., Suzuki, N., Yoshida, M., et al. (2012) · International Journal of Hematology · doi:10.1007/s12185-012-1210-y · Cited by 125
Diagnosis and antimicrobial therapy of lung infiltrates in febrile neutropenic patients: Guidelines of the infectious diseases working party of the German Society of Haematology and Oncology
Maschmeyer, G., Beinert, T., Buchheidt, D., Cornely, O. A., Einsele, H., Heinz, W., Heußel, C. P., Kahl, C., Kiehl, M. G., Lorenz, J., et al. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2009.05.001 · Cited by 125
Self-citation
Diagnosis of invasive fungal infections in hematology and oncology—guidelines from the Infectious Diseases Working Party in Haematology and Oncology of the German Society for Haematology and Oncology (AGIHO)
Ruhnke, M., Böhme, A., Buchheidt, D., Cornely, O. A., Donhuijsen, K., Einsele, H., Enzensberger, R., Hebart, H. F., Heußel, C. P., Horger, M., et al. (2011) · Annals of Oncology · doi:10.1093/annonc/mdr407 · Cited by 125
Self-citation
Parainfluenza Virus Lower Respiratory Tract Disease After Hematopoietic Cell Transplant: Viral Detection in the Lung Predicts Outcome
Seo, S., Xie, H., Campbell, A. P., Kuypers, J. M., Leisenring, W. M., Englund, J. A., & Boeckh, M. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu134 · Cited by 125
Use and Limits of (1-3)-β- d -Glucan Assay (Fungitell), Compared to Galactomannan Determination (Platelia Aspergillus), for Diagnosis of Invasive Aspergillosis
Sulahian, A., Porcher, R., Bergeron, A., Touratier, S., Raffoux, E., Ménotti, J., Derouin, F., & Ribaud, P. (2014) · Journal of Clinical Microbiology · doi:10.1128/jcm.03567-13 · Cited by 124
Anti‐Aspergillus human host defence relies on type 1 T helper (Th1), rather than type 17 T helper (Th17), cellular immunity
Chai, L. Y. A., van de Veerdonk, F. L., Marijnissen, R. J., Cheng, S., Khoo, A. L., Hectors, M. P. C., Lagrou, K., Vonk, A. G., Maertens, J. A., Joosten, L. A. B., et al. (2009) · Immunology · doi:10.1111/j.1365-2567.2009.03211.x · Cited by 126
Self-citation
Antifungal stewardship considerations for adults and pediatrics
Hamdy, R. F., Zaoutis, T. E., & Seo, S. K. (2016) · Virulence · doi:10.1080/21505594.2016.1226721 · Cited by 124
Self-citation
Prevalence of Co-infection at the Time of Hospital Admission in COVID-19 Patients, A Multicenter Study
Karaba, S. M., Jones, G. F., Helsel, T., Smith, L., Avery, R. K., Dzintars, K., Salinas, A. B., Keller, S. C., Townsend, J., Klein, E. Y., et al. (2020) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaa578 · Cited by 127
Population-based surveillance for scedosporiosis in Australia: epidemiology, disease manifestations and emergence of Scedosporium aurantiacum infection
Heath, C. H., Slavin, M. A., Sorrell, T. C., Handke, R., Harun, A. B., Phillips, M. R., Nguyen, Q. A., Delhaès, L., Ellis, D., Meyer, W., et al. (2009) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2009.02802.x · Cited by 123
Self-citation
Clinical and economic burden of invasive fungal diseases in Europe: focus on pre-emptive and empirical treatment of Aspergillus and Candida species
Drgoňa, Ľ., Khachatryan, A., Stephens, J., Charbonneau, C., Kantecki, M., Haider, S., & Barnes, R. A. (2013) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-013-1944-3 · Cited by 124
Laboratory Diagnosis of Invasive Aspergillosis: From Diagnosis to Prediction of Outcome
Barton, R. (2013) · Scientifica · doi:10.1155/2013/459405 · Cited by 122
Low prevalence of resistance to azoles in Aspergillus fumigatus in a French cohort of patients treated for haematological malignancies
Alanio, A., Sitterlé, E., Liance, M., Farrugia, C., Foulet, F., Botterel, F., Hicheri, Y., Cordonnier, C., Costa, J., & Bretagne, S. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq450 · Cited by 122
Detection of Circulating Mucorales DNA in Critically Ill Burn Patients: Preliminary Report of a Screening Strategy for Early Diagnosis and Treatment
Legrand, M. M., Gits‐Muselli, M., Boutin, L., Garcia‐Hermoso, D., Maurel, V., Soussi, S., Benyamina, M., Ferry, A., Chaussard, M., Hamane, S., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw563 · Cited by 123
β-D-glucan Surveillance with Preemptive Anidulafungin for Invasive Candidiasis in Intensive Care Unit Patients: A Randomized Pilot Study
Hanson, K. E., Pfeiffer, C. D., Lease, E. D., Balch, A. H., Zaas, A. K., Perfect, J. R., & Alexander, B. D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042282 · Cited by 124
Self-citation
Galactomannan and Polymerase Chain Reaction–Based Screening for Invasive Aspergillosis Among High-Risk Hematology Patients: A Diagnostic Meta-analysis
Arvanitis, M., Anagnostou, T., & Mylonakis, E. E. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ555 · Cited by 119
Graft-versus-Host Disease Prophylaxis in Unrelated Peripheral Blood Stem Cell Transplantation with Post-Transplantation Cyclophosphamide, Tacrolimus, and Mycophenolate Mofetil
Moiseev, I., Pirogova, O. V., Alyanski, A. L., Babenko, E. V., Gindina, T., Darskaya, E. I., Slesarchuk, O. A., Bondarenko, S. N., & Afanasyev, B. V. (2016) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2016.03.004 · Cited by 119
Serial monitoring of isavuconazole blood levels during prolonged antifungal therapy
Furfaro, E., Signori, A., Grazia, C. D., Dominietto, A., Raiola, A. M., Aquino, S., Ghiggi, C., Ghiso, A., Ungaro, R., Angelucci, E., et al. (2019) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkz188 · Cited by 119
Self-citation
The Y238X Stop Codon Polymorphism in the Human β-Glucan Receptor Dectin-1 and Susceptibility to Invasive Aspergillosis
Chai, L. Y. A., de Boer, M. G. J., van der Velden, W. J. F. M., Plantinga, T. S., van Spriel, A. B., Jacobs, C. W. M., Halkes, C. J. M., Vonk, A. G., Blijlevens, N. M. A., van Dissel, J. T., et al. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiq102 · Cited by 120
Self-citation
Voriconazole pharmacokinetics and exposure–response relationships: Assessing the links between exposure, efficacy and toxicity
Dolton, M. J., & McLachlan, A. J. (2014) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2014.05.019 · Cited by 118
Invasive Fungal Infections in Patients with Chronic Granulomatous Disease
Henriet, S., Verweij, P. E., Holland, S. M., & Warris, A. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-4726-9_3 · Cited by 118
Contemporary management and clinical outcomes of mucormycosis: A systematic review and meta-analysis of case reports
Jeong, W., Keighley, C., Wolfe, R. S., Lee, W. L., Slavin, M. A., Chen, S. C. ‐., & Kong, D. C. M. (2019) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2019.01.002 · Cited by 118
Efficacy and safety of voriconazole and CYP2C19 polymorphism for optimised dosage regimens in patients with invasive fungal infections
Wang, T., Zhu, H.-F., Sun, J., Cheng, X., Xie, J., Dong, H., Chen, L., Wang, X. B., Xing, J., & Dong, Y. (2014) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2014.07.013 · Cited by 118
Anforderungen an die Hygiene bei der medizinischen Versorgung von immunsupprimierten Patienten
über, W. F. D. M. G. K. G. (2010) · Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz · doi:10.1007/s00103-010-1028-9 · Cited by 117
Histoplasmosis, An Underdiagnosed Disease Affecting People Living With HIV/AIDS in Brazil: Results of a Multicenter Prospective Cohort Study Using Both Classical Mycology Tests and Histoplasma Urine Antigen Detection
Falci, D. R., Monteiro, A. A., Caurio, C. F. B., Magalhães, T. C. O., Xavier, M. O., Basso, R. P., de Melo, M. G., Schwarzbold, A. V., Ferreira, P. R. A., Vidal, J. E., et al. (2019) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofz073 · Cited by 117
Pathogenicity and virulence of Aspergillus fumigatus
Earle, K., Valero, C., Conn, D. P., Vere, G., Cook, P. C., Bromley, M., Bowyer, P., & Gago, S. (2023) · Virulence · doi:10.1080/21505594.2023.2172264 · Cited by 121
Index to Predict Invasive Mold Infection in High-Risk Neutropenic Patients Based on the Area Over the Neutrophil Curve
Portugal, R. D., Garnica, M. M., & Nucci, M. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.21.0856 · Cited by 117
A prospective randomized controlled trial comparing PCR-based and empirical treatment with liposomal amphotericin B in patients after allo-SCT
Hebart, H. F., Klingspor, L., Klingebiel, T. E., Loeffler, J., Tollemar, J. G., Ljungman, P. T., Wandt, H., Schaefer‐Eckart, K., Dornbusch, H. J., Meisner, C., et al. (2008) · Bone Marrow Transplantation · doi:10.1038/bmt.2008.355 · Cited by 116
Clinical Perspectives in the Diagnosis and Management of Histoplasmosis
Azar, M. M., & Hage, C. A. (2017) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2017.04.004 · Cited by 116
Monitoring of alphatorquevirus DNA levels for the prediction of immunosuppression-related complications after kidney transplantation
Fernández‐Ruiz, M., Albert, E., Giménez, E., Ruiz‐Merlo, T., Parra, P., López‐Medrano, F., Juan, R. S., Polanco, N., Andrés, A., Navarro, D., et al. (2018) · American Journal of Transplantation · doi:10.1111/ajt.15145 · Cited by 116
Difficulties in using 1,3-β-d-glucan as the screening test for the early diagnosis of invasive fungal infections in patients with haematological malignancies – high frequency of false-positive results and their analysis
Ráčil, Z., Kocmanová, I., Lengerová, M., Weinbergerová, B., Burešová, L., Tošková, M., Winterová, J., Timilsina, S., Rodríguez, I. E., & Mayer, J. (2010) · Journal of Medical Microbiology · doi:10.1099/jmm.0.019299-0 · Cited by 115
Multiplex Blood PCR in Combination with Blood Cultures for Improvement of Microbiological Documentation of Infection in Febrile Neutropenia
Lamoth, F., Jaton, K., Prod’hom, G., Senn, L., Billé, J., Calandra, T., & Marchetti, O. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.00147-10 · Cited by 115
Self-citation
Performance of Targeted Fungal Sequencing for Culture-Independent Diagnosis of Invasive Fungal Disease
Gómez, C. A., Budvytiene, I., Zemek, A., & Banaei, N. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix728 · Cited by 115
Increasing Incidence of Mucormycosis in University Hospital, Belgium
Saegeman, V., Maertens, J. A., Meersseman, W., Spriet, I., Verbeken, E. V., & Lagrou, K. (2010) · Emerging infectious diseases · doi:10.3201/eid1609.100276 · Cited by 115
Self-citation

Authors: De Pauw, B., Walsh, T. J., Donnelly, J. P., Stevens, D. A., Edwards, J. E., Calandra, T., Pappas, P. G., Maertens, J., Lortholary, O., Kauffman, C. A., Denning, D. W., Patterson, T. F., Maschmeyer, G., Bille, J., Dismukes, W. E., Herbrecht, R., Hope, W. W., Kibbler, C. C., Kullberg, B. J., Marr, K. A., Muñoz, P., Odds, F. C., Perfect, J. R., Restrepo, A., Ruhnke, M., Segal, B. H., Sobel, J. D., Sorrell, T. C., Viscoli, C., Wingard, J. R., Zaoutis, T., & Bennett, J. E.
Affiliations: Radboud University Medical Center (NL)
Corresponding author: Donnelly, J. Peter
ORCID: Walsh, Thomas J.
Donnelly, J. Peter
Stevens, David A.
Edwards, John E.
Calandra, Thierry
Pappas, Peter G.
Maertens, Johan
Lortholary, Olivier
Denning, David W.
Patterson, Thomas F.
Maschmeyer, Georg
Herbrecht, Raoul
Hope, William W.
Kullberg, Bart Jan
Marr, Kieren A.
Perfect, John R.
Ruhnke, Markus
Segal, Brahm H.
Sobel, Jack D.
Sorrell, Tania C.
Wingard, John R.
Zaoutis, Theoklis
Bennett, John E.
Venue: Clinical Infectious Diseases
Publisher: Oxford University Press (OUP)
Published: 2008-06-15
Volume: 46
Issue: 12
Pages: 1813-1821
ISSN: 1058-4838 (ISSN-L)
1537-6591
DOI: 10.1086/588660
PMC: PMC2671227
OpenAlex: W2166734004
Cited by: 4,917
References: 28
Citations by year: 2026: 85 · 2025: 146 · 2024: 169 · 2023: 172 · 2022: 203 · 2021: 280 · 2020: 362 · 2019: 424 · 2018: 383 · 2017: 354 · 2016: 345 · 2015: 376 · 2014: 363 · 2013: 299 · 2012: 279
FWCI: 140.34
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Clinical Infectious Diseases (publishedVersion)
PubMed (publishedVersion)
Institutional Repository University of Antioquia (University of Antioquia) (publishedVersion, cc-by-nc-nd)
PubMed Central (acceptedVersion)
IRIS (submittedVersion)
UCL Discovery (University College London) (submittedVersion)
CINECA IRIS Institutial Research Information System (University of Genoa) (submittedVersion)
Research Explorer (The University of Manchester) (submittedVersion)
Radboud Repository (Radboud University) (submittedVersion)
SERVAL (Université de Lausanne) (submittedVersion, other-oa)
Radboud Repository (Radboud University) (submittedVersion, other-oa)
Funders: Amgen
Pfizer
GlaxoSmithKline
Sanofi
Gilead Sciences
Children's Hospital of Philadelphia
Wayne State University
University of Pennsylvania
Wellcome Trust
Valeant Pharmaceuticals International
European Commission
University of Aberdeen
European Organisation for Research and Treatment of Cancer
Astellas Pharma
Centre Hospitalier Universitaire Vaudois
Basilea Pharmaceutica
Italfarmaco
National Institutes of Health
University at Buffalo
Medical School, University of Michigan
University of Texas Health Science Center at San Antonio
Medical Research Council
National Health and Medical Research Council
National Institute of Allergy and Infectious Diseases (Z01AI000654)
Janssen Pharmaceuticals
UCB Pharma
Daiichi Sankyo Europe
Topics: Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
Health Sciences › Medicine › Oncology › Neutropenia and Cancer Infections
Keywords: invasive fungal infections, diagnostic definitions, immunocompromised patients, clinical trial endpoints, fungal epidemiology
MeSH terms: Humans, Mycoses, Terminology as Topic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks